Cycloserine |
D-cycloserin; D-cycloserine; Seromycin |
Article: Cycloserine
![]() | |
| Cycloserine | |
| Systematic (IUPAC) name | |
| 4-aminoisoxazolidin-3-one | |
| Identifiers | |
| CAS number | 68-41-7 |
| ATC code | J04AB01 |
| PubChem | 401 |
| DrugBank | APRD00894 |
| Chemical data | |
| Formula | C3H6N2O2 |
| Mol. weight | 102.092 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
It is oral broad spectrum antibiotic effective against tuberculosis, it inhibits cell wall synthesis of TB bacilli at early stage of peptidoglycan synthesis.
Being trialed for treatment of phobias.
Side effects mainly CNS manifestations i.e. headache, irritability, depression, convulsions.
Categories: Articles lacking sources | Tuberculosis | Antibiotics

Not Signed In - 


